BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 11011299)

  • 1. Mammographic screening and mammographic patterns.
    Day N; Warren R
    Breast Cancer Res; 2000; 2(4):247-51. PubMed ID: 11250716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening.
    Román M; Quintana MJ; Ferrer J; Sala M; Castells X
    Br J Cancer; 2017 May; 116(11):1480-1485. PubMed ID: 28427083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Low-Dose Tamoxifen to Increase Mammographic Screening Sensitivity in Premenopausal Women.
    Eriksson M; Czene K; Conant EF; Hall P
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33467653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors.
    Bhatt R; van den Hout A; Antoniou AC; Shah M; Ficorella L; Steggall E; Easton DF; Pharoah PDP; Pashayan N
    Cancer; 2024 May; 130(9):1590-1599. PubMed ID: 38174903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative analysis of risk factor associations with interval and screen-detected breast cancers: A large UK prospective study.
    Barnes I; Garcia-Closas M; Gathani T; Sweetland S; Floud S; Reeves GK;
    Int J Cancer; 2024 Apr; ():. PubMed ID: 38669116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead-Time Corrected Effect on Breast Cancer Survival in Germany by Mode of Detection.
    Schumann L; Hadwiger M; Eisemann N; Katalinic A
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Random effects models of tumour growth for investigating interval breast cancer.
    Orsini L; Czene K; Humphreys K
    Stat Med; 2024 May; ():. PubMed ID: 38747450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk feedback to women in the UK NHS breast screening population.
    Evans DG; Donnelly LS; Harkness EF; Astley SM; Stavrinos P; Dawe S; Watterson D; Fox L; Sergeant JC; Ingham S; Harvie MN; Wilson M; Beetles U; Buchan I; Brentnall AR; French DP; Cuzick J; Howell A
    Br J Cancer; 2016 Apr; 114(9):1045-52. PubMed ID: 27022688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for breast cancer with mammography.
    Gøtzsche PC; Jørgensen KJ
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001877. PubMed ID: 23737396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An audit of screening for familial breast cancer before 50 years in the South Thames Region - have we got it right?
    Murday V; Pears R; Ball J; Eeles R; Hodgson S
    Fam Cancer; 2004; 3(1):29-34. PubMed ID: 15131403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening.
    Yen AM; Duffy SW; Chen TH; Chen LS; Chiu SY; Fann JC; Wu WY; Su CW; Smith RA; Tabár L
    Cancer; 2012 Dec; 118(23):5728-32. PubMed ID: 22605639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
    Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
    APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammography in symptomatic and asymptomatic patients.
    Stomper PC; Gelman RS
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial.
    Nixon RM; Pharoah P; Tabar L; Krusemo UB; Duffy SW; Prevost TC; Chen HH
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):325-31. PubMed ID: 11011299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology.
    Tabar L; Fagerberg G; Chen HH; Duffy SW; Gad A
    J Med Screen; 1995; 2(2):94-8. PubMed ID: 7497163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.